These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16765213)

  • 1. Pasteurization is effective against multidrug-resistant bacteria.
    Wang CY; Wu HD; Lee LN; Chang HT; Hsu YL; Yu CJ; Yang PC; Hsueh PR
    Am J Infect Control; 2006 Jun; 34(5):320-2. PubMed ID: 16765213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
    Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
    J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of multidrug resistant bacteria in a Tunisian hospital].
    Thabet L; Messadi Aa; Mbarek M; Turki A; Meddeb B; Ben Redjeb S
    Tunis Med; 2008 Nov; 86(11):992-5. PubMed ID: 19213491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for multidrug-resistant bacteria.
    Giamarellou H
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):601-18. PubMed ID: 17009940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
    Kuo LC; Yu CJ; Kuo ML; Chen WN; Chang CK; Lin HI; Chen CC; Lu MC; Lin CH; Hsieh WF; Chen LW; Chou Y; Huang MS; Lee CH; Chen SC; Thai SL; Chen PC; Chen CH; Tseng CC; Chen YS; Hsiue TR; Hsueh PR
    Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
    Nseir S; Ader F; Marquette CH; Durocher A
    Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of multidrug resistant surgical site infections.
    Weese JS
    Vet Comp Orthop Traumatol; 2008; 21(1):1-7. PubMed ID: 18288338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
    Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Common antimicrobial-resistant bacteria in nosocomial infections in Taiwan and their prevention].
    Lin NT
    Hu Li Za Zhi; 2011 Aug; 58(4):5-10. PubMed ID: 21809281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries.
    Lagamayo EN
    Am J Infect Control; 2008 May; 36(4 Suppl):S101-8. PubMed ID: 18468549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
    Lee CY; Chen PY; Huang FL; Lin CF
    J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens.
    Reitzel RA; Dvorak TL; Hachem RY; Fang X; Jiang Y; Raad I
    Am J Infect Control; 2009 May; 37(4):294-300. PubMed ID: 19155100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors.
    Tao C; Kang M; Chen Z; Xie Y; Fan H; Qin L; Ma Y
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):268-70. PubMed ID: 19135331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.